California Compliance Context for Med Spa and Weight-Loss Operators The Assembly Floor Analysis discusses compounded weight-loss drugs in connection with ingredient sourcing, quality-control documentation, and advertising disclosures
Tirzepatide's dual-action mechanism has shown greater average weight loss in clinical trials, but semaglutide has a longer track record and remains highly effective for many patients
Le P, Tatar M, Dasarathy S, Alkhouri N, Herman WH, Taksler GB, et al
There is growing evidence that the microbiome may be critical for establishing, maintaining, and reversing obesity 14,15,16 , and that both diet composition and adiposity each contribute to modulation of the mouse gut microbiome profile 49
Never Share a MOUNJARO KwikPen Between Patients Advise patients that they must never share a MOUNJARO KwikPen with another person, even if the pen needle is changed, because doing so carries a risk for transmission of blood-borne pathogens [see Warnings and Precautions ( 5.10 )]